UmbriaExplore our travel guides. Share your stories, tips and questions on Reddit.
Fast movers • Alerts • Momentum
10% OFF with SAVE10
Charts • Watchlists • Multi-broker tools
Built for active traders
Biotech catalyst, news and analysis PDUFA tracker
Biotech catalyst, news and analysis PDUFA tracker
Educational Guides for Smarter Market Research
Merlintrader Educational brings together practical guides designed to help readers understand the forces that move biotech, healthcare, technology, energy, space and small-cap stocks. The focus is not on predicting the next winner, but on learning how to evaluate evidence, identify risk and place market-moving headlines in the right context.
The articles below explain subjects such as FDA and PDUFA decisions, clinical-trial results, biotech valuation, cash runway and dilution, market structure, technical analysis and trading psychology. Broader sector guides also explore emerging technologies, critical minerals, artificial intelligence, space economics and other themes shaping today’s markets. Whenever possible, real companies and market events are used as worked examples to connect theory with situations investors and traders may encounter in practice.
Browse the latest educational articles below to strengthen your research process, challenge common market myths and develop a more disciplined approach to volatile stocks. All content is provided strictly for educational and informational purposes and does not constitute investment advice.
What makes health insurance growth valuable? Read premiums, care costs, reserves and capital across Centene $CNC, CVS Health $CVS, Oscar $OSCR and UnitedHealth $UNH.
Compare $ABT, $DXCM, $PODD and $SENS through glucose sensing, insulin delivery, patient persistence, access, margins and the conditional iLet integration.
Ulcerative colitis explained through AbbVie $ABBV, Abivax $ABVX, Johnson & Johnson $JNJ and Spyre $SYRE: clinical evidence, access, capital and competition.
Compare Bitcoin holdings with shares, collateral, lending and debt. CleanSpark, HIVE, MARA and Riot show why mining output and shareholder exposure diverge.
Aeroplan’s minority deal and Air Canada’s buyback meet the cash economics of AAdvantage, SkyMiles and MileagePlus. Four airlines, four different ownership claims.
Takeda’s orexin approval changes narcolepsy. Compare Alkermes, Axsome and Jazz through clinical evidence, existing patients, launch timing and business exposure.
CrowdStrike, Castellum, Palo Alto and Zscaler: recurring revenue, funded contracts, acquisition effects and cash conversion across four security stocks.
C3.ai, Salesforce, Microsoft and SoundHound: paid adoption, revenue quality, margins, cash and LivePerson integration in a four-stock AI agents analysis.
A reactor test, an approved design, a fuel contract and commercial electricity are different milestones. A detailed comparison of Oklo, NuScale, Centrus and BWXT follows the current primary evidence, financial obligations, fuel chain and remaining steps between plans and cash-generating operations.
A launch, an operational satellite, a paid service and a cash receipt are different milestones. This detailed comparison follows Rocket Lab, AST SpaceMobile, Intuitive Machines and Redwire through mission evidence, current filings, changed business perimeters, revenue recognition and financing.
A defense selection, a contract ceiling and a funded production order describe different commercial events. This detailed comparison follows Ondas, Red Cat, AeroVironment and Kratos through actual awards, accounting recognition, factory investment, acquisition financing and cash collection.
A geopolitical agreement does not turn a deposit into a qualified magnet. This detailed comparison follows Critical Metals, MP Materials, USA Rare Earth and Energy Fuels from their actual products through processing, customer acceptance and financing, separating completed milestones from future targets.
AI contracts can reach extraordinary sizes while the infrastructure behind them still needs funding. A detailed comparison of CoreWeave, Nebius, IREN and Oracle follows the money from customer commitments through delivery, debt service and the residual available to shareholders.
Audio, display and VR glasses are different businesses. A detailed guide to Meta Connect, Qualcomm's silicon, Google's Android XR and Apple's ecosystem explains what is available, what is still planned and where economic evidence remains missing.
IonQ's planned NVIDIA research-center installation makes hybrid quantum computing tangible. A source-led comparison explains what it means for four companies, which milestones remain ahead and how to separate a working application from a compelling announcement.
From demonstrations to paying customers: how to read PhotonLink, new lasers and AI optics orders without confusing technological promise with commercial results.
The next frontier in obesity treatment also concerns what happens after weight loss. Viking’s September 22 results sharpen the question: how much of the benefit can be preserved, for how long, and with what burden of treatment and side effects?
How $ONDS, $RCAT, $DPRO and $AVAV are turning defense autonomy into an industry: orders, manufacturing, cash, dilution and the next execution tests.
Nobody plans it. You do some research, you buy a small position, and eleven months later you are defending a company at two in the morning. The seven people in every ticker feed, the dictionary of the smitten, the four bills, and a cold test in four questions.
A framework for reading the critical-minerals sector: why the real bottleneck is processing (the midstream), a four-question tool to triage any headline, with $UAMY as the worked example and $MP, $USAR and $TMC on the map.